Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial. (Q40211674)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 2014

Language	Label	Description	Also known as
English	Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial.	scientific article published on April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Magali Traskine

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jens U Rüggeberg

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Dorota Borys

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

0 references

publication date

1 April 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

3025-3034

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24699466%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Serotype replacement in disease after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Issues and challenges in the development of pneumococcal protein vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.066

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40211674&oldid=1486513456"